No CrossRef data available.
Article contents
Leucopenia y neutropenia inducidas por risperidona: un caso clínico
Published online by Cambridge University Press: 12 May 2020
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Caso clínico
- Information
- Copyright
- Copyright © European Psychiatric Association 2004
References
Bibliografía
Mahmood, T., Silverstone, T., Spittle, B., Rispendone appears to be safe in patients with antipsychotic-induced blood dyscrasias. Int Clin Psychopharmacol 1996;11:53–4.CrossRefGoogle ScholarPubMed
Dernovsek, Z., Tavcar, R., Risperidone-induced leucopenia and nentropenia. Br J Psychiatry 1997;171:393–4.CrossRefGoogle Scholar
Finkel, B., Lemer, A.G., Oyffe, I., Sigal, M., Risperidone-associated agranulocytosis. Am J Psychiatry 1998;155:6.Google ScholarPubMed
Bondolfi, G., Morena, P., Dascal, D., Bertschy, G., Risperidone and reversible neutropenia: a negative rechallenge. Eur Neuropsychopharmacol 1996;6:257.CrossRefGoogle ScholarPubMed
Hong, X., Wang, X., Agranulocytosis and neutropenia with typical and atypical neuroleptics. Am J Psychiatry 2001;158:1736–7.CrossRefGoogle ScholarPubMed
Godleski, L.S., Semyak, MJ., Agranulocytosis after addition of risperidone to clozapine treatment. Am J Psychiatry 1996;153:735–6.Google ScholarPubMed